Search research articles
Contact Us
Filters
Showing results (21-30 of 160) with videos related to
Page
of 16
Sort By:
BMC Infectious Diseases
|
May 20, 2011
Systematic review of influenza resistance to the neuraminidase inhibitors
Kristian Thorlund, Tahany Awad, Guy Boivin, et al.
Systematic Reviews
|
October 15, 2014
The risk of elevated prolactin levels in pediatric patients exposed to antipsychotics for the treatment of schizophrenia and schizophrenia spectrum disorders: protocol for a systematic review and meta-analysis
Eric Druyts, Shawn Eapen, Ping Wu, et al.
BMJ Open
|
August 14, 2016
False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review
Georgina Imberger, Kristian Thorlund, Christian Gluud, et al.
International Journal of Epidemiology
|
October 1, 2008
Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses
Jesper Brok, Kristian Thorlund, Jørn Wetterslev, et al.
Clinical Epidemiology
|
April 3, 2018
Critical concepts in adaptive clinical trials
Jay Jh Park, Kristian Thorlund, Edward J Mills
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology
|
May 21, 2014
Hepatitis C intervention research - Where are we now and where should we be heading?
Tahany Awad, Kristian Thorlund, Mahasen Mabrouk, et al.
Gates Open Research
|
July 2, 2019
Highly Efficient Clinical Trials Simulator (HECT): Software application for planning and simulating platform adaptive trials
Kristian Thorlund, Shirin Golchi, Jonas Haggstrom, et al.
BMJ (Clinical Research Ed.)
|
May 16, 2013
Demystifying trial networks and network meta-analysis
Edward J Mills, Kristian Thorlund, John P A Ioannidis
Journal of Medical Economics
|
January 29, 2015
Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis
Kabirraaj Toor, Eric Druyts, Jeroen P Jansen, et al.
British Journal of Clinical Pharmacology
|
September 28, 2022
Infliximab as a second-line therapy for children with refractory Kawasaki disease: A systematic review and meta-analysis of randomized controlled trials
Suad Kabbaha, Alyssa Milano, Mamoon A Aldeyab, et al.
Page
of 16
Search research articles
Search
Showing results (21-30 of 160) with videos related to
Sort By:
Page
of 16
BMC Infectious Diseases
|
May 20, 2011
Systematic review of influenza resistance to the neuraminidase inhibitors
Kristian Thorlund, Tahany Awad, Guy Boivin, et al.
Systematic Reviews
|
October 15, 2014
The risk of elevated prolactin levels in pediatric patients exposed to antipsychotics for the treatment of schizophrenia and schizophrenia spectrum disorders: protocol for a systematic review and meta-analysis
Eric Druyts, Shawn Eapen, Ping Wu, et al.
BMJ Open
|
August 14, 2016
False-positive findings in Cochrane meta-analyses with and without application of trial sequential analysis: an empirical review
Georgina Imberger, Kristian Thorlund, Christian Gluud, et al.
International Journal of Epidemiology
|
October 1, 2008
Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses
Jesper Brok, Kristian Thorlund, Jørn Wetterslev, et al.
Clinical Epidemiology
|
April 3, 2018
Critical concepts in adaptive clinical trials
Jay Jh Park, Kristian Thorlund, Edward J Mills
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology
|
May 21, 2014
Hepatitis C intervention research - Where are we now and where should we be heading?
Tahany Awad, Kristian Thorlund, Mahasen Mabrouk, et al.
Gates Open Research
|
July 2, 2019
Highly Efficient Clinical Trials Simulator (HECT): Software application for planning and simulating platform adaptive trials
Kristian Thorlund, Shirin Golchi, Jonas Haggstrom, et al.
BMJ (Clinical Research Ed.)
|
May 16, 2013
Demystifying trial networks and network meta-analysis
Edward J Mills, Kristian Thorlund, John P A Ioannidis
Journal of Medical Economics
|
January 29, 2015
Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis
Kabirraaj Toor, Eric Druyts, Jeroen P Jansen, et al.
British Journal of Clinical Pharmacology
|
September 28, 2022
Infliximab as a second-line therapy for children with refractory Kawasaki disease: A systematic review and meta-analysis of randomized controlled trials
Suad Kabbaha, Alyssa Milano, Mamoon A Aldeyab, et al.
Page
of 16